U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

 Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period.

The Patient Monitoring Devices Market generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027.

Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period.

Based on end-user, the hospitals segment accounted for the largest share in 2019, holding more than half of the total share, and is expected to maintain the largest share throughout the forecast period. However, the home setting segment is expected to register the highest CAGR of 5.0% from 2020 to 2027.

Based on region, North America contributed the highest share, accounting for more than two-fifths of the total market share in 2019, and will maintain its dominance throughout the forecast period. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% from 2020 to 2027.

The leading companies, such as Medtronic Plc., Biotronik, and Boston Scientific Corporation, have adopted – product development and partnership strategies to improve their market share and positioning.

Key Findings of the Remote Patient Monitoring (RPM) Market:

• CHF was the leading segment in 2015, and is expected to maintain its lead throughout the analysis period.
• Diabetes will be the fastest growing segment throughout the analysis period.
• Devices will be both the highest revenue generating and fastest growing segment of the global remote patient monitoring (RPM) market.
• Saudi Arabia market for remote patient monitoring is projected to grow at a high CAGR of 21.3%.
• U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

Leading market players analyzed in the research include Biotronik, Medtronic, Inc., GE Healthcare Ltd, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Masimo Corporation, Omron Healthcare Co. Ltd, Johnson and Johnson, Koninklijke Philips N.V., and Abbott Laboratories.

Read More: https://www.alliedmarketresearch.com/press-release/remote-patient-monitoring-market.html